×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
LON:BERM

Bermele (BERM) Share Forecast, Price & News

GBX 0.70
-0.30 (-30.00%)
(As of 04/22/2021)
Add
Compare
Today's Range
0.70
0.70
50-Day Range
0.70
0.70
52-Week Range
0.70
1
Volume
5.00 million shs
Average Volume
425,138 shs
Market Capitalization
£1.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BERM News and Ratings via Email

Sign-up to receive the latest news and ratings for Bermele and its competitors with MarketBeat's FREE daily newsletter.

About Bermele

Bermele plc does not have significant operations. It intends to acquire business or businesses operating in the pharmaceutical and biotechnology sectors. The company was incorporated in 2017 and is based in London, the United Kingdom.

Headlines

East Imper Regulatory News
Readmission - Bermele PLC
Bermele PLC : Proposed Acquisition of East Imperial Pte. Ltd.
Bermele PLC : Holding(s) in Company
Berm.l Share Price (BERM)
Berm.l Share Chat
Bermele plc (BERM.L)
See More Headlines

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.10 per share
Book Value
GBX 0.10 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£1.55 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.80 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Bermele (LON:BERM) Frequently Asked Questions

What other stocks do shareholders of Bermele own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bermele investors own include Agronomics (ANIC), Aston Martin Lagonda Global (AML), Amigo (AMGO), Amur Minerals (AMC), Aminex (AEX), Aditxt (ADTX), Adamis Pharmaceuticals (ADMP), Acasti Pharma (ACST), Abal Group (ABAL) and American Airlines Group (AAL).

What is Bermele's stock symbol?

Bermele trades on the London Stock Exchange (LON) under the ticker symbol "BERM."

How do I buy shares of Bermele?

Shares of BERM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Bermele's stock price today?

One share of BERM stock can currently be purchased for approximately GBX 0.70.

How much money does Bermele make?

Bermele has a market capitalization of £1.55 million.

How many employees does Bermele have?

Bermele employs 1 workers across the globe.

What is Bermele's official website?

The official website for Bermele is bermele.com.

How can I contact Bermele?

The company can be reached via phone at 44 20 3475 9760.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.